Colorectal Cancer Screening and Surveillance



Worldwide, colorectal cancer causes approximately 600,000 deaths per year [1]. About 16,000 of these occur in the UK, where it is the second commonest cause of cancer death. Despite advances in surgery and adjuvant therapies, 5-year survival remains around 50% [2].


Colorectal Cancer Lynch Syndrome Fecal Occult Blood Testing Flexible Sigmoidoscopy Colonoscopic Surveillance 


  1. 1.
    WHO. Cancer, fact sheet number 297. Geneva: World Health Organisation, 2009. Accessed 22 Nov 2011
  2. 2.
    Cancer Research UK. By stage at diagnosis. London: Cancer Research UK, 2009. Accessed 22 Nov 2011.
  3. 3.
    Atkin W, Morson B, Cuzik J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992;326:658–62.PubMedCrossRefGoogle Scholar
  4. 4.
    Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977–81.PubMedCrossRefGoogle Scholar
  5. 5.
    Burch JA, Soares-Weiser K, St John DJB, et al. Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. J Med Screen. 2007;14:132–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer: a population based, case-controlled study. Ann Intern Med. 2009;150:1–8.PubMedGoogle Scholar
  7. 7.
    Brenner H, Hoffmeister M, Arndt V, et al. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst. 2010;102:89–95.PubMedCrossRefGoogle Scholar
  8. 8.
    Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer using faecal occult-blood test. Lancet. 1996;348:1467–71.PubMedCrossRefGoogle Scholar
  9. 9.
    Kewenter J, Brevinge H, Engaras B, et al. Results of screening, rescreening and follow up in a prospective randomized study for detection of colorectal cancer by fecal occult-blood testing: results of 68,308 subjects. Scand J Gastroenterol. 1994;29:468–73.PubMedCrossRefGoogle Scholar
  10. 10.
    Mandel JS, Bond JH, Church TR, et al. Reducing mortality by screening for fecal occult blood. N Engl J Med. 1993;328:1365–71.PubMedCrossRefGoogle Scholar
  11. 11.
    Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Hewitson P, Gasziou P, Irwig L, et al. Cochrane systematic review of colorectal cancer screening using the faecal occult blood test (haemoccult): an update. Am J Gastroenterol. 2008;103:1541–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Atkin WS, Edwards R, Kralj-Hans I, et al. One-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;9276:1624–33.CrossRefGoogle Scholar
  14. 14.
    Weller D, Coleman D, Robertson R, et al. The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer. 2007;97:1601–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Tappenden P, Chilcott J, Eggington S, et al. Option appraisal of population-based colorectal cancer screening programmes in England. Gut. 2007;56:677–84.PubMedCrossRefGoogle Scholar
  16. 16.
    Robb KA, Miles A, Wardle J. Demographic and psychosocial factors associated with perceived risk for colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2004;13:366–72.PubMedGoogle Scholar
  17. 17.
    Cairns SR, Scholefield JH, Steele RJ, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59:666–89.PubMedCrossRefGoogle Scholar
  18. 18.
    Atkin W, Saunders B. Surveillance guidelines after removal of colorectal adenomatous polyps. Gut. 2002;51(Suppl5):V6–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Vasen HFA, Mšslein G, Alonso A, et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut. 2008;57:704–13.PubMedCrossRefGoogle Scholar
  20. 20.
    Boparai KS, Reitsma JB, Lemmens V, et al. Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome. Gut. 2010;59:1222–5.PubMedCrossRefGoogle Scholar
  21. 21.
    Beggs AD, Latchford AR, Vasen HF, et al. Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut. 2010;59:975–86.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2012

Authors and Affiliations

  1. 1.The Polyposis RegistrySt Mark’s HospitalMiddlesex, LondonUK

Personalised recommendations